Upacicalcet sodium is a novel chemical compound primarily investigated for its potential therapeutic applications, particularly in the treatment of conditions related to calcium metabolism, such as secondary hyperparathyroidism. As a calcium-sensing receptor (CaSR) modulator, it functions by mimicking the action of calcium in the body, thereby helping to regulate parathyroid hormone (PTH) secretion. This compound is characterized by its sodium salt form, which enhances its solubility and bioavailability. Upacicalcet sodium is typically administered orally and has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion. Its efficacy and safety profile are evaluated through clinical trials, focusing on its ability to lower serum PTH levels and improve calcium homeostasis without causing significant adverse effects. As research continues, Upacicalcet sodium represents a promising advancement in the management of calcium-related disorders, although further studies are necessary to fully understand its long-term effects and potential applications in clinical practice.

Upacicalcet sodium

2052969-18-1: Upacicalcet sodium is a novel chemical compound primarily investigated for its potential therapeutic applications, particularly in the treatment of conditions related to calcium metabolism, such as secondary hyperparathyroidism. As a calcium-sensing receptor (CaSR) modulator, it functions by mimicking the action of calcium in the body, thereby helping to regulate parathyroid hormone (PTH) secretion. This compound is characterized by its sodium salt form, which enhances its solubility and bioavailability. Upacicalcet sodium is typically administered orally and has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion. Its efficacy and safety profile are evaluated through clinical trials, focusing on its ability to lower serum PTH levels and improve calcium homeostasis without causing significant adverse effects. As research continues, Upacicalcet sodium represents a promising advancement in the management of calcium-related disorders, although further studies are necessary to fully understand its long-term effects and potential applications in clinical practice.

CAS 2052969-18-1

Upacicalcet sodium

Upacicalcet (sodium)

Ref: 54-OR1115498

Upacicalcet Sodium Salt

Ref: 4Z-U-117001